SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: Buckeye who wrote (302)2/3/1999 11:27:00 PM
From: synchro  Respond to of 656
 
The temptation for me during the past few weeks has been to short against the box and buy some more on the pull back. But I didn't pull the trigger due to a combination of hope, fear and laziness. Now that the markets have some facts to trade on -- and I have to agree that the facts are somewhat of a downer -- chances are the stock will dive from the stratopheric level. My attitude is that I have waited for this stock since it was in the low teens, I can wait a little longer.

My greater fear is for Enbrel to have some kind of long term side effect that has yet to show up in trials and tests. Then you're talking a real downward gapper. No indication of that so far though.
The talk of expanding the label sounds intriguing, we'll just have to see.

Now if they can just get those cancer tumor compounds to work on humans....